These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 17714766

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
    ter Borg EJ, Kelder JC.
    Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rituximab therapy in primary Sjögren's syndrome.
    Alcântara C, Gomes MJ, Ferreira C.
    Ann N Y Acad Sci; 2009 Sep; 1173():701-5. PubMed ID: 19758218
    [Abstract] [Full Text] [Related]

  • 6. Rituximab in primary Sjögren's syndrome: a ten-year journey.
    Carubbi F, Alunno A, Cipriani P, Bartoloni E, Ciccia F, Triolo G, Gerli R, Giacomelli R.
    Lupus; 2014 Nov; 23(13):1337-49. PubMed ID: 25096066
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of Sjögren's syndrome: current therapy and future directions.
    Fox RI, Fox CM, Gottenberg JE, Dörner T.
    Rheumatology (Oxford); 2021 May 14; 60(5):2066-2074. PubMed ID: 31034046
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Primary Sjögren's syndrome: new clinical and therapeutic concepts.
    Ramos-Casals M, Tzioufas AG, Font J.
    Ann Rheum Dis; 2005 Mar 14; 64(3):347-54. PubMed ID: 15498797
    [Abstract] [Full Text] [Related]

  • 14. Management of patients presenting with Sjogren's syndrome.
    Venables PJ.
    Best Pract Res Clin Rheumatol; 2006 Aug 14; 20(4):791-807. PubMed ID: 16979538
    [Abstract] [Full Text] [Related]

  • 15. Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome.
    Rihl M, Ulbricht K, Schmidt RE, Witte T.
    Rheumatology (Oxford); 2009 Jul 14; 48(7):796-9. PubMed ID: 19433433
    [Abstract] [Full Text] [Related]

  • 16. Use of Biologics in Sjögren's Syndrome.
    Nocturne G, Cornec D, Seror R, Mariette X.
    Rheum Dis Clin North Am; 2016 Aug 14; 42(3):407-17. PubMed ID: 27431344
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biologic treatments in Sjögren's syndrome.
    Bowman S, Barone F.
    Presse Med; 2012 Sep 14; 41(9 Pt 2):e495-509. PubMed ID: 22836195
    [Abstract] [Full Text] [Related]

  • 19. Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sjögren's syndrome.
    Verstappen GM, Moerman RV, van Nimwegen JF, van Ginkel MS, Bijzet J, Mossel E, Vissink A, Hazenberg BPC, Arends S, Kroese FGM, Bootsma H.
    Rheumatology (Oxford); 2018 Oct 01; 57(10):1812-1821. PubMed ID: 29982712
    [Abstract] [Full Text] [Related]

  • 20. Safety of treatments for primary Sjögren's syndrome.
    van Nimwegen JF, Moerman RV, Sillevis Smitt N, Brouwer E, Bootsma H, Vissink A.
    Expert Opin Drug Saf; 2016 Oct 01; 15(4):513-24. PubMed ID: 26809028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.